Lupin gets USFDA nod for asthmatic symptoms prevention drug

Lupin gets USFDA nod for asthmatic symptoms prevention drug In a regulatory filing, Lupin said it has received approval from the United States Food and Drug Administration (USFDA) for its Albuterol Sulfate Inhalation Aerosol, 90 mcg (base)/actuation.

No comments:

Post a Comment